The development direction of the pharmaceutical equipment industry is gradually clear, and the future transformation and upgrading will continue to accelerate

Under the current rapid development of the emerging biopharmaceutical industry and the accelerated transformation of the pharmaceutical industry, the development of the pharmaceutical equipment industry is also accelerating
.
It is understood that in recent years, with the continuous increase of the state's policy guidance and support for the pharmaceutical industry, as well as the continuous development and accumulation of domestic pharmaceutical equipment enterprises, China's pharmaceutical equipment industry has developed rapidly in terms of technical level, product quality, product variety specifications and other aspects, and the gap with foreign pharmaceutical equipment enterprises is gradually narrowing
.

 

The development direction of the pharmaceutical equipment industry is gradually clear! (Image source: Pharmaceutical Network)
 

In addition, the current development direction of the pharmaceutical equipment industry has gradually become clear
.
First of all, many pharmaceutical equipment companies are strengthening technological innovation and product renewal to break the situation of high product overlap rate and enhance market competitiveness
.
It is worth noting that the current needs of pharmaceutical companies are diversified, and in the case of rising costs year by year, the overall solution provider can better meet the needs of enterprises than the research and development of a single pharmaceutical equipment, so this has also become a major direction
for the innovation and upgrading of many domestic pharmaceutical equipment companies.

 

For example, the prospectus for the issuance of A-shares to specific targets in 2022 released by Dongfulong shows that the total amount of funds raised by the issuance of shares to specific targets does not exceed 3.
2 billion yuan (including this number), and it is intended to be used to invest in the biopharmaceutical equipment industry trial production center project, the Jiangsu biomedical equipment industrialization base project, the life science industrialization base project of Zhejiang Dongfulong Biotechnology Co.
, Ltd.
and supplementary working capital
.

 

In addition, Singapore and Malaysia Pharma is building a pharmaceutical equipment industrialization project
.
After the completion of the project, it will form a solid preparation-laboratory, customized, production-type, airtight production line of the whole industrial chain
.

 

It is worth mentioning that after Chutian Technology continues to increase investment in the field of bioengineering technology, technological innovation achievements and achievements have been growing
rapidly in recent years.
According to Chutian Technology's 2022 interim report, the revenue related to bioengineering solutions and stand-alone business increased by 191.
29%
year-on-year.
At present, Chutian Technology has basically completed the layout
of the whole industry chain from the preparation equipment of the front-end of biopharmaceuticals to the production equipment of gene and cell therapy drugs.

 

In addition to accelerating innovation, promoting intelligent manufacturing has also become one of the development trends of
the pharmaceutical equipment industry.
This is also the development trend of China's manufacturing industry, or become a "chip" for future enterprises to divide the victory and defeat in the market
.
In fact, intelligence has long become an important starting
point for pharmaceutical companies to reduce costs and increase efficiency and promote the high-quality development of the pharmaceutical industry.
Pharmaceutical equipment is an important means of pharmaceutical production, representing the level of pharmaceutical industry production, affecting the improvement
of drug quality.
Therefore, in the context of the current pharmaceutical industry to promote intelligent transformation, the intelligentization of pharmaceutical equipment is also accelerating
.

 

It is understood that on April 20, Dongfulong made it clear at the 2021 annual performance briefing that it will firmly focus on the development strategy of "systematization, internationalization and digitalization", in the field of aseptic injection, biological engineering and other pharmaceutical equipment, closely focus on the production process and development direction of drugs, develop innovative products with forward-looking and independent intellectual property rights, improve research and development efficiency, increase innovation, and provide global pharmaceutical customers with competitive and brand influence of the overall system solutions
.

 

Canaan Technology in recent years is also accelerating the transformation from "manufacturing" to "intelligent manufacturing", in the second half of 2021, its total investment of 1 billion yuan of intelligent medical equipment manufacturing projects, there are 3 standardized production workshops have been completed, the rest are planned to be completed
in 2023.

 

In January 2022, the Ministry of Industry and Information Technology and other nine departments jointly issued the "14th Five-Year Plan for the Development of the Pharmaceutical Industry", which focuses on the in-depth implementation of intelligent manufacturing, green manufacturing and quality improvement actions, improving the quality management level and product quality of drugs and medical devices throughout the life cycle, and promoting the high-end, intelligent and green development of
the pharmaceutical industry.
The industry expects that in this context, pharmaceutical equipment companies will continue to improve in product intelligence, and the pharmaceutical equipment industry will usher in huge changes
in the future.